Professor Berners-Price has a high international reputation in the field of medicinal inorganic chemistry. A major advance has been the new perspective she has provided to gold-based therapeutics, showing that they can be rationally designed as versatile drugs for a range of human diseases caused by dysfunction of selenol and thiol containing proteins. Her application of NMR-based methods to study the speciation and biomolecular interactions of platinum anticancer agents has provided unique mechanistic insight that has influenced the design of clinical agents. As a Principal Research Leader in Griffith’s Institute for Glycomics she has spearheaded the development of a new area of endeavour in the field of bioinorganic chemistry - metalloglycomics – the interaction of defined coordination compounds with oligosaccharides. She obtained her PhD in Chemistry from Birkbeck College, University of London and has held academic and senior administrative positions at both Griffith University and the University of Western Australia. She is the author of more than 125 peer-reviewed original research articles and is a Fellow of both the Royal Society of Chemistry and the Royal Australian Chemical Institute. She is the current President of the Society of Biological Inorganic Chemistry (2019-2020) and the recipient of the 2018 Asian Biological Inorganic Chemistry (AsBIC) Outstanding Achievement Award. Professor Berners-Price is Dean of the Griffith Graduate Research and the current Convenor of the Australian Council of Graduate Research (2018–2019).